“Pharmaceutical manufacturers say high U.S. prices support research and development and point out that Americans tend to get new treatments first. But recent research has shown that the price of a drug is related neither to the amount of research and development required to bring it […]
“‘We’ve asked Kaiser Permanente management questions about the deal’s advantages to employees and customers, but we haven’t heard back,’ said Caroline Lucas, the executive director of the Coalition of Kaiser Permanente Unions, several of which are in contentious contract talks with the company. ‘Where […]
Action Alert Register here for Zoom Webinar “The Pathway to Single Payer Healthcare in California” August 24, 2023 at 5 pm PT Sponsors Courage Campaign, California Alliance for Retired Americans & Health Care for All-California _____________________________ Breaking News in Healthcare Reform […]
“After decades of unchecked mergers, health care is the land of giants, with one or two huge medical systems monopolizing care top to bottom in many cities, states, and even whole regions of the country. Reams of economic research show that the level of […]
“With tens of millions of Americans burdened by medical debt, hospitals and other medical providers are increasingly shuttling their patients into loans serviced by banks, credit cards, and other financial services companies.” What One Lending Company’s Hospital Contracts Reveal About Financing […]
Breaking News in Healthcare Reform Snippets of news & commentary with a special focus on health policy, Medicare for All & California _________________________________________________________________________________________________ Like Weekly News Roundup? Then you’ll love our popular podcast Code WACK! where we shine a light on the […]
“Teens who land in emergency rooms with an opioid overdose generally receive naloxone to reverse the effects of dangerous drugs in their system and are sent home with a list of places they can go for follow-up care. But too often, those teens never […]
“The anti-amyloid drugs like lecanemab have created a polarized environment in medicine between those who think the drugs are a dangerous waste of money and those who believe they are a brilliant first step to a cure, said ICER’s Rind, who thinks lecanemab […]
